CVS Corp (CVS) 97.43 $CVS
Covered Call reports for Kinder Morgan, Valero Energy, SodaStream, CVS Caremark and AmerisourceBergen include trade ideas that offer returns of 20% or more!
PR Newswire - Wed Aug 03, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABC, CVS, KMI, SODA, and VLO.
KMI: 20.13 (+0.34), VLO: 54.71 (+2.36), ABC: 89.89 (+0.46), CVS: 97.43 (-0.63), SODA: 27.48 (-0.77)
CVS Health, Adapt Pharma Team Up to Discount NARCAN Price
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:38PM CDT
CVS Health and Adapt Pharma recently announced a partnership aimed at making the opioid overdose-reversing drug NARCAN Nasal Spray more affordable for patients without insurance coverage.
BABY: 38.40 (-0.05), MASI: 53.18 (+0.64), CVS: 97.43 (-0.63), MLAB: 105.13 (-3.14)
Business Highlights
By The Associated Press - AP - Tue Aug 02, 4:19PM CDT
___
F: 12.13 (+0.19), PFE: 35.29 (-1.10), GM: 30.24 (+0.31), CVS: 97.43 (-0.63), TM: 110.07 (+0.10), PG: 85.97 (-0.79), AET: 116.86 (+1.15)
Royal Caribbean and General Motors fall; CVS advances
AP - Tue Aug 02, 3:51PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
MNK: 79.66 (+2.75), DISCK: 25.91 (+0.50), F: 12.13 (+0.19), DAL: 36.48 (+0.09), PFE: 35.29 (-1.10), STX: 30.73 (+0.08), DISCB: 25.82 (-0.03), DISCA: 26.83 (+0.41), CVS: 97.43 (-0.63), GM: 30.24 (+0.31)
CVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:39PM CDT
CVS Health Corporation (CVS) reported second-quarter 2016 adjusted earnings per share (EPS) of $1.32, up 8.2% year over year.
LMAT: 17.59 (+0.20), QDEL: 23.02 (+0.30), CVS: 97.43 (-0.63), NUVA: 62.76 (+0.13)
Watch for CVS Caremark to Potentially Pullback After Gaining 4.55% Yesterday
Comtex SmarTrend(R) - Tue Aug 02, 11:55AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.62 to a high of $98.42. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $94.05 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)
CVS Caremark Rises 4.55% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 02, 11:54AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.62 to a high of $98.42. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $94.05 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)
Q2 Earnings Reports Come in Mixed, Futures Down Slightly
Mark Vickery - Zacks Investment Research - Tue Aug 02, 8:58AM CDT
Q2 earnings season may have passed the midway point last week, but plenty of important companies are reporting earnings this morning: PFE, PG, MNT, CVS, SODA and RCL.
RCL: 68.77 (+1.42), PFE: 35.29 (-1.10), CVS: 97.43 (-0.63), PG: 85.97 (-0.79), SODA: 27.48 (-0.77)
Kleenex® Facial Cleansing Products Now Available Through World's Largest E-tailers
PR Newswire - Tue Aug 02, 7:37AM CDT
Kleenex® brand, the inventor of the facial tissue category and trusted for its exceptional softness, announces the roll-out of its Kleenex® Facial Cleansing collection across major e-tailers, including Amazon, Target.com, Walmart.com, CVS.com, Fresh Direct, Peapod, Walgreens.com and Ulta.com beginning late July 2016 and continuing through early September. All retail sites will offer products from the collection, which includes the Facial Cleansing Wipes, Exfoliating Cushions, Eye Makeup Removers and Cotton Soft Pads.
KMB: 128.89 (-1.92), CVS: 97.43 (-0.63)
CVS Health (CVS) Beats Earnings, Misses Revenues in Q2
Aparajita Dutta - Zacks Investment Research - Tue Aug 02, 7:34AM CDT
CVS Health's (CVS0 adjusted earnings per share of $1.32 beat the Zacks Consensus estimate by 1.5%.
CVS: 97.43 (-0.63)
CVS Health Reports Second Quarter Results
PR Newswire - Tue Aug 02, 5:55AM CDT
Second Quarter Year-over-year Highlights:
CVS: 97.43 (-0.63)
3 Stocks to Watch Before the Market Opens Tomorrow
ESTMZ - Mon Aug 01, 3:46PM CDT
CVS : The pharmacy giant is coming off a better than expected first quarter which saw sales rise by 19% and earnings jump by 4%. Unfortunately, investors didn’t see any of those gains as the stock is down 4% year to date. Key factors for the quarter...
RCL: 68.77 (+1.42), SPY: 216.18 (+0.63), CCL: 45.63 (+0.37), TGT: 74.10 (+0.21), CVS: 97.43 (-0.63), SODA: 27.48 (-0.77)
CVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance through Improved Affordability of NARCAN® Nasal Spray at CVS Pharmacy Locations
PR Newswire - Fri Jul 29, 9:11AM CDT
CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN® (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. Through this partnership, CVS Pharmacy patients purchasing NARCAN® Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication, reducing the out-of-pocket cost by nearly 25 percent. NARCAN® Nasal Spray is the first and only FDA-approved, ready-to-use nasal formulation of naloxone for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is available in a convenient box containing two units (each unit delivers a concentrated 4mg dose of active medication-naloxone hydrochloride- in a .1ml mist) for immediate use if the need arises.
CVS: 97.43 (-0.63)
Stock Market News for July 28, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:10AM CDT
Benchmarks closed mixed on Wednesday following the Federal Open Market Committee’s (FOMC) policy statement and key earnings results.
KO: 43.64 (+0.11), PM: 99.03 (-0.94), XOM: 87.49 (+0.45), COST: 166.12 (-0.38), CVS: 97.43 (-0.63), PG: 85.97 (-0.79), MO: 66.37 (-0.97), CVX: 100.61 (+1.02), BA: 131.87 (+0.27), CMCSA: 66.84 (-0.06), AAPL: 105.79 (+1.31)
CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 130.43 (-0.16), CVS: 97.43 (-0.63), BMY: 74.80 (-0.25), HOLX: 39.00 (-0.03)
SmarTrend Watching for Potential Pullback in Shares of CVS Caremark After 1.05% Gain
Comtex SmarTrend(R) - Wed Jul 13, 11:51AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.53 to a high of $97.69. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $97.21 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)
CVS Health (CVS) Works to Cut Down on Readmission Rates
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 5:33PM CDT
The study on medication reconciliation program by CVS Health resulted in total savings of over $1300 per patient.
HLF: 67.04 (+0.25), DPLO: 37.02 (+1.04), CVS: 97.43 (-0.63)
MinuteClinic Announces New Travel Health Services Just in Time for Summer Vacation Season
PR Newswire - Thu Jul 07, 7:00AM CDT
To help patients prepare for a safe and healthy travel season this summer and beyond, MinuteClinic, the walk-in medical clinics inside select CVS Pharmacy and Target stores nationwide, has added several new travel-related services and immunizations.
CVS: 97.43 (-0.63)
Covered Call reports for Kinder Morgan, Valero Energy, SodaStream, CVS Caremark and AmerisourceBergen include trade ideas that offer returns of 20% or more!
PR Newswire - Wed Aug 03, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABC, CVS, KMI, SODA, and VLO.
KMI: 20.13 (+0.34), VLO: 54.71 (+2.36), ABC: 89.89 (+0.46), CVS: 97.43 (-0.63), SODA: 27.48 (-0.77)
CVS Health, Adapt Pharma Team Up to Discount NARCAN Price
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:38PM CDT
CVS Health and Adapt Pharma recently announced a partnership aimed at making the opioid overdose-reversing drug NARCAN Nasal Spray more affordable for patients without insurance coverage.
BABY: 38.40 (-0.05), MASI: 53.18 (+0.64), CVS: 97.43 (-0.63), MLAB: 105.13 (-3.14)
Business Highlights
By The Associated Press - AP - Tue Aug 02, 4:19PM CDT
___
F: 12.13 (+0.19), PFE: 35.29 (-1.10), GM: 30.24 (+0.31), CVS: 97.43 (-0.63), TM: 110.07 (+0.10), PG: 85.97 (-0.79), AET: 116.86 (+1.15)
Royal Caribbean and General Motors fall; CVS advances
AP - Tue Aug 02, 3:51PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
MNK: 79.66 (+2.75), DISCK: 25.91 (+0.50), F: 12.13 (+0.19), DAL: 36.48 (+0.09), PFE: 35.29 (-1.10), STX: 30.73 (+0.08), DISCB: 25.82 (-0.03), DISCA: 26.83 (+0.41), CVS: 97.43 (-0.63), GM: 30.24 (+0.31)
CVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:39PM CDT
CVS Health Corporation (CVS) reported second-quarter 2016 adjusted earnings per share (EPS) of $1.32, up 8.2% year over year.
LMAT: 17.59 (+0.20), QDEL: 23.02 (+0.30), CVS: 97.43 (-0.63), NUVA: 62.76 (+0.13)
Watch for CVS Caremark to Potentially Pullback After Gaining 4.55% Yesterday
Comtex SmarTrend(R) - Tue Aug 02, 11:55AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.62 to a high of $98.42. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $94.05 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)
CVS Caremark Rises 4.55% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 02, 11:54AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.62 to a high of $98.42. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $94.05 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)
Q2 Earnings Reports Come in Mixed, Futures Down Slightly
Mark Vickery - Zacks Investment Research - Tue Aug 02, 8:58AM CDT
Q2 earnings season may have passed the midway point last week, but plenty of important companies are reporting earnings this morning: PFE, PG, MNT, CVS, SODA and RCL.
RCL: 68.77 (+1.42), PFE: 35.29 (-1.10), CVS: 97.43 (-0.63), PG: 85.97 (-0.79), SODA: 27.48 (-0.77)
Kleenex® Facial Cleansing Products Now Available Through World's Largest E-tailers
PR Newswire - Tue Aug 02, 7:37AM CDT
Kleenex® brand, the inventor of the facial tissue category and trusted for its exceptional softness, announces the roll-out of its Kleenex® Facial Cleansing collection across major e-tailers, including Amazon, Target.com, Walmart.com, CVS.com, Fresh Direct, Peapod, Walgreens.com and Ulta.com beginning late July 2016 and continuing through early September. All retail sites will offer products from the collection, which includes the Facial Cleansing Wipes, Exfoliating Cushions, Eye Makeup Removers and Cotton Soft Pads.
KMB: 128.89 (-1.92), CVS: 97.43 (-0.63)
CVS Health (CVS) Beats Earnings, Misses Revenues in Q2
Aparajita Dutta - Zacks Investment Research - Tue Aug 02, 7:34AM CDT
CVS Health's (CVS0 adjusted earnings per share of $1.32 beat the Zacks Consensus estimate by 1.5%.
CVS: 97.43 (-0.63)
CVS Health Reports Second Quarter Results
PR Newswire - Tue Aug 02, 5:55AM CDT
Second Quarter Year-over-year Highlights:
CVS: 97.43 (-0.63)
3 Stocks to Watch Before the Market Opens Tomorrow
ESTMZ - Mon Aug 01, 3:46PM CDT
CVS : The pharmacy giant is coming off a better than expected first quarter which saw sales rise by 19% and earnings jump by 4%. Unfortunately, investors didn’t see any of those gains as the stock is down 4% year to date. Key factors for the quarter...
RCL: 68.77 (+1.42), SPY: 216.18 (+0.63), CCL: 45.63 (+0.37), TGT: 74.10 (+0.21), CVS: 97.43 (-0.63), SODA: 27.48 (-0.77)
CVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance through Improved Affordability of NARCAN® Nasal Spray at CVS Pharmacy Locations
PR Newswire - Fri Jul 29, 9:11AM CDT
CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN® (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. Through this partnership, CVS Pharmacy patients purchasing NARCAN® Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication, reducing the out-of-pocket cost by nearly 25 percent. NARCAN® Nasal Spray is the first and only FDA-approved, ready-to-use nasal formulation of naloxone for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is available in a convenient box containing two units (each unit delivers a concentrated 4mg dose of active medication-naloxone hydrochloride- in a .1ml mist) for immediate use if the need arises.
CVS: 97.43 (-0.63)
Stock Market News for July 28, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:10AM CDT
Benchmarks closed mixed on Wednesday following the Federal Open Market Committee’s (FOMC) policy statement and key earnings results.
KO: 43.64 (+0.11), PM: 99.03 (-0.94), XOM: 87.49 (+0.45), COST: 166.12 (-0.38), CVS: 97.43 (-0.63), PG: 85.97 (-0.79), MO: 66.37 (-0.97), CVX: 100.61 (+1.02), BA: 131.87 (+0.27), CMCSA: 66.84 (-0.06), AAPL: 105.79 (+1.31)
CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 130.43 (-0.16), CVS: 97.43 (-0.63), BMY: 74.80 (-0.25), HOLX: 39.00 (-0.03)
SmarTrend Watching for Potential Pullback in Shares of CVS Caremark After 1.05% Gain
Comtex SmarTrend(R) - Wed Jul 13, 11:51AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.53 to a high of $97.69. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $97.21 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)
CVS Health (CVS) Works to Cut Down on Readmission Rates
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 5:33PM CDT
The study on medication reconciliation program by CVS Health resulted in total savings of over $1300 per patient.
HLF: 67.04 (+0.25), DPLO: 37.02 (+1.04), CVS: 97.43 (-0.63)
MinuteClinic Announces New Travel Health Services Just in Time for Summer Vacation Season
PR Newswire - Thu Jul 07, 7:00AM CDT
To help patients prepare for a safe and healthy travel season this summer and beyond, MinuteClinic, the walk-in medical clinics inside select CVS Pharmacy and Target stores nationwide, has added several new travel-related services and immunizations.
CVS: 97.43 (-0.63)
